Chemomab Therapeutics Ltd ADR (CMMB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2006 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 17,575 | 7,517 | 1,454 | 4,564 | N/A |
| Receivables | N/A | 3,403 | 400 | 868 | N/A |
| TOTAL | $18,211 | $10,920 | $1,854 | $5,432 | $N/A |
| Non-Current Assets | |||||
| PPE Net | 158 | 385 | 219 | 213 | N/A |
| Other Non-Current Assets | 1,386 | 1,456 | 14 | 10 | 0 |
| TOTAL | $1,544 | $1,841 | $233 | $223 | $N/A |
| Total Assets | $19,755 | $12,761 | $2,087 | $5,655 | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 875 | 2,102 | 2,541 | 2,218 | 0 |
| Accrued Expenses | 2,855 | 644 | 155 | 141 | N/A |
| TOTAL | $4,121 | $2,746 | $2,696 | $2,359 | $N/A |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 725 | 210 | 0 | 0 | 0 |
| TOTAL | $725 | $210 | $N/A | $N/A | $N/A |
| Total Liabilities | $4,846 | $2,956 | $2,696 | $2,359 | $N/A |
| Shareholders' Equity | |||||
| Retained earnings | -105,431 | -78,307 | -62,876 | -53,070 | N/A |
| Other shareholders' equity | 872 | 872 | 2,224 | 1,383 | 0 |
| TOTAL | $14,909 | $9,805 | $-609 | $3,296 | $N/A |
| Total Liabilities And Equity | $19,755 | $12,761 | $2,087 | $5,655 | $0 |